Fidler I J
Cancer Res. 1975 Jan;35(1):218-24.
Successive B16 melanoma tumor lines were selected for their ability to form pulmonary tumor nodules. This was accomplished by injecting tumor cells i.v. into syngeneic C57BL/6 mice and 2 to 3 weeks later collecting the secondary tumor growths and placing them into tissue culture. These tumor cells were then injected i.v. into new syngeneic mice and the process was repeated several times. With each successive tumor line the number of experimental lung tumor nodules was significantly increased. The B16 lines were found to be stable in their metastatic properties even after many subculturings in vitro. These studies demonstrated that tumor cells that succeed in forming pulmonary tumor colonies also had increased invasive properties into normal tissues when implanted s.c. In addition, the tumor cell lines were prelabeled in vitro with [125-I]-5-iodo-2'-deoxyuridine and suspensions of labeled cells were injected i.v. into normal syngeneic hosts. Animals were killed at intervals afterwards, and the lungs and blood were processed and monitored for radioactivity. At any time interval, the lungs of mice treated by injections of cells of high metastatic yield contained more tumor cells. The differences in tumor cell numbers in the lungs were most pronounced immediately following i.v. injection. These results suggest that an increased initial arrest of highly metastatic cells in a capillary bed may be a major factor in their increased survival. Low numbers of normal lymphocytes or lymphocytes from syngeneic mice immunized to the B16 melanoma, when mixed in vitro with the tumor cells, lead to the formation of multitumor cell-lymphocyte clumps. The degree of clumping was related to both the type of the metastatic tumor line and/or the syngeneic lymphocyte. These results support the hypothesis that the survival of invasive and/or circulating malignant tumor cells is not a random phenomenon; rather it appears that malignant cells possess unique qualities which allow for their survival.
连续选择具有形成肺肿瘤结节能力的B16黑色素瘤肿瘤系。这是通过将肿瘤细胞静脉注射到同基因C57BL/6小鼠体内来实现的,2至3周后收集继发性肿瘤生长物并将其置于组织培养中。然后将这些肿瘤细胞静脉注射到新的同基因小鼠体内,该过程重复几次。随着连续的肿瘤系,实验性肺肿瘤结节的数量显著增加。发现B16系即使在体外多次传代培养后其转移特性仍保持稳定。这些研究表明,成功形成肺肿瘤集落的肿瘤细胞在皮下植入时对正常组织的侵袭性也增强。此外,肿瘤细胞系在体外预先用[125-I]-5-碘-2'-脱氧尿苷标记,标记细胞的悬液静脉注射到正常同基因宿主中。此后每隔一段时间处死动物,对肺和血液进行处理并监测放射性。在任何时间间隔,注射高转移率细胞的小鼠肺中含有更多的肿瘤细胞。静脉注射后立即,肺中肿瘤细胞数量的差异最为明显。这些结果表明,高转移性细胞在毛细血管床中初始滞留增加可能是其存活率增加的主要因素。少量正常淋巴细胞或来自免疫过B16黑色素瘤的同基因小鼠的淋巴细胞,在体外与肿瘤细胞混合时,会导致形成多肿瘤细胞-淋巴细胞团块。团块程度与转移肿瘤系的类型和/或同基因淋巴细胞均有关。这些结果支持以下假设:侵袭性和/或循环性恶性肿瘤细胞的存活不是随机现象;相反,恶性细胞似乎具有使其存活的独特特性。